Skip to main content
. 2023 Aug 21;13:13567. doi: 10.1038/s41598-023-40883-2

Table 1.

The baseline clinical characteristics.

Total, N = 235
Demographics
 Age, y 67 ± 10
 Male, n (%) 199 (84.7)
 Body surface area, m2 1.729 ± 0.181
Medical history
 History of MI, n (%) 40 (17.0)
 Hypertension, n (%) 182 (77.4)
 Hyperlipidemia, n (%) 135 (57.4)
 Diabetes mellitus, n (%) 93 (39.6)
 Current smoker, n (%) 44 (18.7)
 Family history, n (%) 32 (13.6)
Laboratory data
 LDL-chol, mg dL−1 87 [72–111]
 Creatinine, mg dL−1 0.84 [0.72–0.96]
 HbA1c, % 6.2 [5.8–6.9]
 NT-proBNP, ng L−1 124 [59–315]
 Hs-cTnI at presentation, ng L−1 6 [3–12]
 Peak hs-cTnI, ng L−1 320 [113–953]
 Peak CK, IU L−1 101 [69–163]
 Peak CK-MB, IU L−1 11 [8–15]
Coronary angiography
 Target lesion location; RCA/LAD/LCx 58 (24.7)/146 (62.1)/31 (13.2)
 UMI lesion PCI, n (%) 25 (10.6)
 OMI lesion PCI, n (%) 25 (10.6)​
 SYNTAX score 14 [9–18]
Pre-PCI
 Diameter stenosis, % 73.7 [65.8–81.4]
 Lesion length, mm 15.2 [10.9–20.0]
 FFR 0.64 [0.50–0.73]
Post-PCI
 Diameter stenosis, % 10.9 [7.9–14.8]
 FFR 0.88 [0.83–0.93]
 Total stent length, mm 28 [20–40]
 Number of stents, n (%) 1 [1–1]
 Mean stent diameter, mm 3.25 [3.00–3.50]
CMR indices
 EDV, mL 120.1 [102.7–145.4]
 ESV, mL 45.1 [32.8–64.3]
 LVMI, g m−2 77.3 [69.6–89.5]
 EF, % 62.0 [53.8–68.0]
 Unrecognized LGE, g 0.0 [0.0–0.0]
 Post-PCI LGE, g 0.0 [0.0–9.7]
 Increased LGE, g 0.0 [0.0–0.0]

EDV end diastolic volume, EF ejection fraction, ESV end systolic volume, FFR fractional flow reserve, HbA1c glycated hemoglobin, Hs-cTnI high-sensitivity troponin I, LAD left anterior descending coronary artery, LCx left circumflex coronary artery, LDL-chol low density lipoprotein cholesterol, LGE late gadolinium enhancement, LVMI left ventricular mass index, NT-proBNP N-terminal pro-B-type natriuretic peptide, OMI old myocardial infarction, PCI percutaneous coronary intervention, RCA right coronary artery.